| P50 | author | Ruud Veldhuizen | Q60730440 |
| P2093 | author name string | Sean E Gill | |
| | Cory M Yamashita | |
| P2860 | cites work | Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome | Q24685217 |
| | Mechanical ventilation: lessons from the ARDSNet trial | Q24791291 |
| | Alveolar epithelial type II cell: defender of the alveolus revisited | Q24791750 |
| | Bench-to-bedside review: Biotrauma and modulation of the innate immune response. | Q24811500 |
| | Sepsis and Acute Respiratory Distress Syndrome: Recent Update | Q26749485 |
| | Key mechanisms governing resolution of lung inflammation | Q26749606 |
| | Recent advances in understanding and treating ARDS | Q26751256 |
| | The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia | Q26753063 |
| | The Many Alternative Faces of Macrophage Activation | Q26800142 |
| | The role of TIMPs in regulation of extracellular matrix proteolysis | Q27000650 |
| | Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 |
| | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation | Q28271331 |
| | Acute respiratory distress syndrome: the Berlin Definition | Q29615138 |
| | The acute respiratory distress syndrome | Q29615140 |
| | The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 |
| | Personalized contact strategies and predictors of time to survey completion: analysis of two sequential randomized trials | Q30405674 |
| | Gender and acute respiratory distress syndrome in critically injured adults: a prospective study | Q30424763 |
| | Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis | Q40191474 |
| | In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. | Q40261230 |
| | Retinoic acid promotes the endogenous repair of lung stem/progenitor cells in combined with simvastatin after acute lung injury: a stereological analysis | Q40329546 |
| | Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system | Q40575234 |
| | Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions | Q40749386 |
| | Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism | Q40803661 |
| | Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo | Q40996335 |
| | Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis | Q41349763 |
| | Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome | Q41672169 |
| | Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS | Q41672179 |
| | The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. | Q41752313 |
| | Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement | Q41828281 |
| | Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury | Q41837482 |
| | Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis | Q42002715 |
| | Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome | Q42231767 |
| | The role of the extracellular matrix components in cutaneous wound healing | Q42373904 |
| | Rats surviving injurious mechanical ventilation show reversible pulmonary, vascular and inflammatory changes | Q43949233 |
| | Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis | Q44785146 |
| | IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin | Q44882865 |
| | β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury | Q45883480 |
| | Alveolar macrophage inducible nitric oxide synthase-dependent pulmonary microvascular endothelial cell septic barrier dysfunction | Q45883601 |
| | Pulmonary surfactant: functions and molecular composition. | Q46027561 |
| | The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation | Q46440662 |
| | Endothelial-to-mesenchymal transition in lipopolysaccharide-induced acute lung injury drives a progenitor cell-like phenotype | Q46559527 |
| | Neonatal Type II Alveolar Epithelial Cell Transplant Facilitates Lung Reparation in Piglets With Acute Lung Injury and Extracorporeal Life Support | Q47881824 |
| | Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo | Q47916772 |
| | Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice | Q48002326 |
| | Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components | Q48020777 |
| | Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells | Q48545708 |
| | Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice | Q49019201 |
| | Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo | Q50250811 |
| | Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis. | Q50465921 |
| | Transplantation of alveolar type II cells stimulates lung regeneration during compensatory lung growth in adult rats. | Q51395595 |
| | Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo. | Q51530674 |
| | Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. | Q51585412 |
| | Effect of age on the development of ARDS in trauma patients. | Q51659753 |
| | Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. | Q53558161 |
| | Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. | Q53992007 |
| | Modulation of Dietary Lipid Composition During Acute Respiratory Distress Syndrome: Systematic Review and Meta-Analysis | Q38308115 |
| | Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice | Q38325147 |
| | Current incidence and outcome of the acute respiratory distress syndrome | Q38662160 |
| | Stem cell therapy for acute respiratory distress syndrome: a promising future? | Q38662174 |
| | Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers | Q38792971 |
| | What's Next After ARDS: Long-Term Outcomes | Q38819270 |
| | Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies | Q38830673 |
| | Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities | Q38876661 |
| | Prospects and progress in cell therapy for acute respiratory distress syndrome | Q38917280 |
| | Alveolocapillary model system to study alveolar re-epithelialization | Q39269380 |
| | Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy. | Q39499760 |
| | Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome | Q31941514 |
| | Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury | Q33556235 |
| | Commitment and differentiation of lung cell lineages | Q33678429 |
| | Alcohol abuse and pulmonary disease | Q33755478 |
| | Resolution of pulmonary edema. Thirty years of progress | Q33901613 |
| | Epithelial repair mechanisms in the lung | Q33916933 |
| | Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. | Q33980412 |
| | Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis. | Q34021204 |
| | Acute respiratory distress in adults | Q34051677 |
| | Monocyte interaction accelerates HCl-induced lung epithelial remodeling | Q34077093 |
| | Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome | Q34214892 |
| | The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review | Q34387533 |
| | Treatment of ARDS. | Q34395656 |
| | Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions. | Q34580909 |
| | Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization | Q34633354 |
| | Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats | Q34731282 |
| | Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation | Q34774000 |
| | Animal models of acute lung injury | Q34795312 |
| | The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment | Q35025114 |
| | Isolation of alveolar epithelial type II progenitor cells from adult human lungs. | Q35073643 |
| | Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin | Q35085416 |
| | Pulmonary microvascular albumin leak is associated with endothelial cell death in murine sepsis-induced lung injury in vivo | Q35091785 |
| | FoxM1 mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosa | Q35102306 |
| | Vascular pharmacology of acute lung injury and acute respiratory distress syndrome | Q35127980 |
| | Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. | Q35219775 |
| | Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis | Q35235706 |
| | Balance of life and death in alveolar epithelial type II cells: proliferation, apoptosis, and the effects of cyclic stretch on wound healing | Q35325284 |
| | Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury | Q35528061 |
| | In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement. | Q35560012 |
| | Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? | Q35689605 |
| | VEGF-induced vascular permeability is mediated by FAK. | Q35697402 |
| | Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome | Q35738931 |
| | Regulators of endothelial and epithelial barrier integrity and function in acute lung injury | Q35760657 |
| | Resident Endothelial Cells and Endothelial Progenitor Cells Restore Endothelial Barrier Function After Inflammatory Lung Injury | Q35789141 |
| | Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury | Q35809674 |
| | Matrix metalloproteinases as modulators of inflammation and innate immunity | Q35852281 |
| | Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro | Q35855331 |
| | Role of aquaporins in lung liquid physiology | Q35860530 |
| | Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration | Q35945347 |
| | Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability? | Q35982193 |
| | Ventilator-induced lung injury: from the bench to the bedside | Q36288949 |
| | Response to fluid boluses in the fluid and catheter treatment trial | Q36411339 |
| | Clinical implications for vascular endothelial growth factor in the lung: friend or foe? | Q36625050 |
| | Endothelial p110γPI3K Mediates Endothelial Regeneration and Vascular Repair After Inflammatory Vascular Injury | Q36689429 |
| | Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted | Q36712749 |
| | Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection | Q36737913 |
| | Wnt3a Mediates the Inhibitory Effect of Hyperoxia on the Transdifferentiation of AECIIs to AECIs | Q36742578 |
| | Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome | Q36944030 |
| | Metalloproteinases and their inhibitors: regulators of wound healing | Q37033574 |
| | Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury | Q37056490 |
| | The endothelium in acute lung injury/acute respiratory distress syndrome | Q37057202 |
| | Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a | Q37094220 |
| | B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS. | Q37166377 |
| | The role of adherens junctions and VE-cadherin in the control of vascular permeability | Q37195511 |
| | Recent trends in acute lung injury mortality: 1996-2005. | Q37227161 |
| | Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection | Q37264759 |
| | Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. | Q37304335 |
| | Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. | Q37326144 |
| | Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury | Q37591016 |
| | Tissue inhibitor of metalloproteinases-3 moderates the proinflammatory status of macrophages. | Q37596430 |
| | Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches | Q37766848 |
| | Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. | Q37874843 |
| | Lung function and quality of life in survivors of the acute respiratory distress syndrome (ARDS). | Q37955323 |
| | The role of ADAM-mediated shedding in vascular biology. | Q37964357 |
| | Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair | Q38008342 |
| | Genesis of the myofibroblast in lung injury and fibrosis | Q38026812 |
| | Regulation and repair of the alveolar-capillary barrier in acute lung injury | Q38080559 |
| | Epithelial and endothelial damage induced by mechanical ventilation modes | Q38168401 |
| | Regulation of tissue morphogenesis by endothelial cell-derived signals | Q38296261 |
| P433 | issue | 3 | |
| P304 | page(s) | 495-509 | |
| P577 | publication date | 2016-10-29 | |
| P1433 | published in | Cell and Tissue Research | Q1524113 |
| P1476 | title | Lung remodeling associated with recovery from acute lung injury | |
| P478 | volume | 367 | |